These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14968813)

  • 1. Future opportunities & innovative therapies for cardiovascular disease-SMi conference.
    Mazucco RA
    IDrugs; 2004 Jan; 7(1):31-3. PubMed ID: 14968813
    [No Abstract]   [Full Text] [Related]  

  • 2. What future does the pharmaceutical industry have in the cardiovascular world?
    Braunwald E
    Eur Heart J; 2013 Apr; 34(13):943-4. PubMed ID: 23546415
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular pipeline decline quantified.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681785
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular combinations.
    Glass G
    Nat Rev Drug Discov; 2004 Sep; 3(9):731-2. PubMed ID: 15368657
    [No Abstract]   [Full Text] [Related]  

  • 5. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular drugs and dental considerations.
    Wynn RL
    J Calif Dent Assoc; 2000 Jul; 28(7):519-26. PubMed ID: 11324134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy in the elderly.
    Scheidt S; Wenger NK; Weber MA
    Am J Geriatr Cardiol; 2003; 12(4):223-4. PubMed ID: 12888701
    [No Abstract]   [Full Text] [Related]  

  • 8. Promises kept and broken: new pharmaceuticals.
    Malik P
    Can J Cardiol; 2002 May; 18(5):493-4. PubMed ID: 12032574
    [No Abstract]   [Full Text] [Related]  

  • 9. LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders.
    Megson IL; Leslie SJ
    Curr Opin Investig Drugs; 2009 Mar; 10(3):276-85. PubMed ID: 19333886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescriptions in cardiology].
    Vacheron A
    Ann Pharm Fr; 2005 Mar; 63(2):125-30. PubMed ID: 15976679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHARMAC and cardiovascular health in New Zealand.
    Moodie P
    N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinued drugs in 2008: cardiovascular drugs.
    Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2009 Jul; 18(7):875-85. PubMed ID: 19548849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term use of heparin in cardiovascular diseases. Proposal for a new administration method: aerosols].
    Molino N; Belluardo C
    Minerva Cardioangiol; 1973; 21(7):553-7. PubMed ID: 4756349
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular pharmacologic therapies under investigation: 2012.
    Frishman WH; Pallerla K
    Cardiol Rev; 2012; 20(3):102-10. PubMed ID: 22301717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Which future in cardiovascular therapy for nitric oxide and its derivatives?].
    Parent M; Dupuis F; Maincent P; Vigneron C; Leroy P; Boudier A
    Ann Pharm Fr; 2013 Mar; 71(2):84-94. PubMed ID: 23537409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of molecular medicine upon early cardiovascular drug development.
    Lunnon MW; Braddock M
    Br J Clin Pharmacol; 2000 Jul; 50(1):1-8. PubMed ID: 10886110
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitrates and other nitric oxide donors in cardiology: current positioning and perspectives.
    Iachini Bellisarii F; Radico F; Muscente F; Horowitz J; De Caterina R
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):55-69. PubMed ID: 22134686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of atrial fibrillation: an old option with new possibilities.
    Janko S; Dorwarth U; Hoffmann E
    Expert Opin Pharmacother; 2008 Apr; 9(6):913-25. PubMed ID: 18377335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of coronary heart disease with nitric oxide donors].
    Münzel T; Schulz E
    Pharm Unserer Zeit; 2010 Sep; 39(5):359-68. PubMed ID: 20818685
    [No Abstract]   [Full Text] [Related]  

  • 20. Merck Serono targets convenient, affordable medicines for patients at risk.
    Cardiovasc J Afr; 2009; 20(1):77. PubMed ID: 19287822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.